89 related articles for article (PubMed ID: 18787415)
1. scFv-mediated delivery of truncated BID suppresses HER2-positive osteosarcoma growth and metastasis.
Shan LQ; Qiu XC; Xu YM; Ji ZG; Yang TT; Chen X; Ma BA; Zhou Y; Fan QY; Yang AG
Cancer Biol Ther; 2008 Nov; 7(11):1717-22. PubMed ID: 18787415
[TBL] [Abstract][Full Text] [Related]
2. Single-chain antibody/activated BID chimeric protein effectively suppresses HER2-positive tumor growth.
Qiu XC; Xu YM; Wang F; Fan QY; Wang LF; Ma BA; Jia LT; Zhao J; Meng YL; Yao LB; Chen SY; Yang AG
Mol Cancer Ther; 2008 Jul; 7(7):1890-9. PubMed ID: 18644999
[TBL] [Abstract][Full Text] [Related]
3. A caspase-6 and anti-HER2 antibody chimeric tumor-targeted proapoptotic molecule decreased metastasis of human osteosarcoma.
Wang LF; Zhou Y; Xu YM; Qiu XC; Zhou BG; Wang F; Long H; Chen X; Yang TT; Ma BA; Fan QY; Yang AG
Cancer Invest; 2009 Aug; 27(7):774-80. PubMed ID: 19488908
[TBL] [Abstract][Full Text] [Related]
4. Selective cytotoxicity to HER2-positive tumor cells by a recombinant e23sFv-TD-tBID protein containing a furin cleavage sequence.
Wang F; Ren J; Qiu XC; Wang LF; Zhu Q; Zhang YQ; Huan Y; Meng YL; Yao LB; Chen SY; Xu YM; Yang AG
Clin Cancer Res; 2010 Apr; 16(8):2284-94. PubMed ID: 20371697
[TBL] [Abstract][Full Text] [Related]
5. The effect of direct translocation across endosomes on the cytotoxicity of the recombinant protein e23sFv-Fdt-casp6 to HER2 positive gastric cancer cells.
Ren JL; Meng YL; Hu B; Jia LT; Zhang R; Xu YM; Xie QS; Zhang YQ; Jin BQ; Chen SY; Wang T; Yang AG
Biomaterials; 2011 Oct; 32(30):7641-50. PubMed ID: 21767874
[TBL] [Abstract][Full Text] [Related]
6. Construction of humanized anti-HER2 single-chain variable fragments (husFvs) and achievement of potent tumor suppression with the reconstituted husFv-Fdt-tBid immunoapoptotin.
Ou-Yang Q; Yan B; Li A; Hu ZS; Feng JN; Lun XX; Zhang MM; Zhang MD; Wu KC; Xue FF; Yang AG; Zhao J
Biomaterials; 2018 Sep; 178():170-182. PubMed ID: 29935385
[TBL] [Abstract][Full Text] [Related]
7. A novel recombinant immuno-tBid with a furin site effectively suppresses the growth of HER2-positive osteosarcoma cells in vitro.
Shan LQ; Ma S; Qiu XC; Wang T; Yu SB; Ma BA; Zhou Y; Fan QY; Yang AG
Oncol Rep; 2011 Feb; 25(2):325-31. PubMed ID: 21152867
[TBL] [Abstract][Full Text] [Related]
8. A novel recombinant immunocasp-6 fusion gene specifically and efficiently suppresses HER2-overexpressing osteosarcoma.
Zhou BG; Liu MY; Qiu XC; Xu YM; Fan QY; Yang AG; Zhang Y; Xia H
Oncol Rep; 2013 Jan; 29(1):276-82. PubMed ID: 23135254
[TBL] [Abstract][Full Text] [Related]
9. [Pro-apoptotic effect on osteosarcoma SOSP-9607 cells by human recombinant caspase-6 fusion protein].
Zhou BG; Qiu XC; Xu YM; Fan QY
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):497-500. PubMed ID: 21029691
[TBL] [Abstract][Full Text] [Related]
10. Dual targeting and enhanced cytotoxicity to HER2-overexpressing tumors by immunoapoptotin-armored mesenchymal stem cells.
Cai Y; Xi Y; Cao Z; Xiang G; Ni Q; Zhang R; Chang J; Du X; Yang A; Yan B; Zhao J
Cancer Lett; 2016 Oct; 381(1):104-12. PubMed ID: 27473824
[TBL] [Abstract][Full Text] [Related]
11. HER2-targeted recombinant protein immuno-caspase-6 effectively induces apoptosis in HER2-overexpressing GBM cells in vitro and in vivo.
Zhang L; Ren J; Zhang H; Cheng G; Xu Y; Yang S; Dong C; Fang D; Zhang J; Yang A
Oncol Rep; 2016 Nov; 36(5):2689-2696. PubMed ID: 27633091
[TBL] [Abstract][Full Text] [Related]
12. A caspase-6 and anti-human epidermal growth factor receptor-2 (HER2) antibody chimeric molecule suppresses the growth of HER2-overexpressing tumors.
Xu YM; Wang LF; Jia LT; Qiu XC; Zhao J; Yu CJ; Zhang R; Zhu F; Wang CJ; Jin BQ; Chen SY; Yang AG
J Immunol; 2004 Jul; 173(1):61-7. PubMed ID: 15210759
[TBL] [Abstract][Full Text] [Related]
13. p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome.
Nakase M; Inui M; Okumura K; Kamei T; Nakamura S; Tagawa T
Mol Cancer Ther; 2005 Apr; 4(4):625-31. PubMed ID: 15827336
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.
Xu M; Xie Y; Sheng W; Miao J; Yang J
Technol Cancer Res Treat; 2015 Aug; 14(4):369-78. PubMed ID: 25326586
[TBL] [Abstract][Full Text] [Related]
15. The caspase-8/Bid/cytochrome c axis links signals from death receptors to mitochondrial reactive oxygen species production.
Kim WS; Lee KS; Kim JH; Kim CK; Lee G; Choe J; Won MH; Kim TH; Jeoung D; Lee H; Kim JY; Ae Jeong M; Ha KS; Kwon YG; Kim YM
Free Radic Biol Med; 2017 Nov; 112():567-577. PubMed ID: 28888620
[TBL] [Abstract][Full Text] [Related]
16. Drug-regulatable cancer cell death induced by BID under control of the tissue-specific, lung cancer-targeted TTS promoter system.
Fukazawa T; Maeda Y; Matsuoka J; Tanaka N; Tanaka H; Durbin ML; Naomoto Y
Int J Cancer; 2009 Oct; 125(8):1975-84. PubMed ID: 19598260
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor and HER2/neu downregulate expression of apoptosis-inducing factor in non-small cell lung cancer.
Chiang YY; Chow KC; Lin TY; Chiang IP; Fang HY
Oncol Rep; 2014 Feb; 31(2):597-604. PubMed ID: 24276579
[TBL] [Abstract][Full Text] [Related]
18. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
19. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
20. Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [(99m)Tc]-HYNIC-trastuzumab (Herceptin) Fab fragments.
Tang Y; Scollard D; Chen P; Wang J; Holloway C; Reilly RM
Nucl Med Commun; 2005 May; 26(5):427-32. PubMed ID: 15838425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
